Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2020
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells
Martin J Scurr, Alex Greenshields-Watson, Emma Campbell, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
Nwe Ni Than, James Hodson, Daniel Schmidt-Martin, et al.
Multiple Sclerosis and Related Disorders
|
June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
Emma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Cancer Immunology, Immunotherapy : CII
|
July 1, 2015
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Saskia J A M Santegoets, Eveline M Dijkgraaf, Alessandra Battaglia, et al.
Journal of Clinical Immunology
|
June 10, 2024
Lower Humoral and Cellular Immunity Following Asymptomatic SARS-CoV-2 Infection Compared to Symptomatic Infection in Education (The ACE Cohort)
Georgina Hopkins, Nancy Gomez, Davis Tucis, et al.
Cell Reports
|
May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activation
Sarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 27, 2016
Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions
Peter Jönsson, Jennifer H Southcombe, Ana Mafalda Santos, et al.
Annals of Neurology
|
October 23, 2021
COVID-19 Vaccine Response in People with Multiple Sclerosis
Emma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Oncoimmunology
|
May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference
Fereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2020
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells
Martin J Scurr, Alex Greenshields-Watson, Emma Campbell, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
Nwe Ni Than, James Hodson, Daniel Schmidt-Martin, et al.
Multiple Sclerosis and Related Disorders
|
June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
Emma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Cancer Immunology, Immunotherapy : CII
|
July 1, 2015
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Saskia J A M Santegoets, Eveline M Dijkgraaf, Alessandra Battaglia, et al.
Journal of Clinical Immunology
|
June 10, 2024
Lower Humoral and Cellular Immunity Following Asymptomatic SARS-CoV-2 Infection Compared to Symptomatic Infection in Education (The ACE Cohort)
Georgina Hopkins, Nancy Gomez, Davis Tucis, et al.
Cell Reports
|
May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activation
Sarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 27, 2016
Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions
Peter Jönsson, Jennifer H Southcombe, Ana Mafalda Santos, et al.
Annals of Neurology
|
October 23, 2021
COVID-19 Vaccine Response in People with Multiple Sclerosis
Emma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Oncoimmunology
|
May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference
Fereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Page
of 7